I agree that QNTA has great upside potential considering all the positive developments we have seen and the company's diligent work towards further product marketing to a large number of patients who can greatly benefit from the pharmacological advancements that are being delivered. This looks like a very good entry point for QNTA with minimal downside risk.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.